statistiche ricercatore

Continente	#
NA - Nord America	788
AS - Asia	493
EU - Europa	219
SA - Sud America	61
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	2
OC - Oceania	2
Totale	1.583

Nazione	#
US - Stati Uniti d'America	774
SG - Singapore	193
CN - Cina	86
HK - Hong Kong	74
VN - Vietnam	74
SE - Svezia	46
BR - Brasile	44
GB - Regno Unito	39
FI - Finlandia	33
DE - Germania	22
RU - Federazione Russa	22
FR - Francia	11
IN - India	11
BG - Bulgaria	10
IT - Italia	10
KR - Corea	10
AR - Argentina	9
ID - Indonesia	9
CA - Canada	8
ZA - Sudafrica	8
NL - Olanda	7
TR - Turchia	6
AE - Emirati Arabi Uniti	5
BD - Bangladesh	5
PH - Filippine	5
ES - Italia	4
EC - Ecuador	3
MX - Messico	3
SA - Arabia Saudita	3
UA - Ucraina	3
A2 - ???statistics.table.value.countryCode.A2???	2
AU - Australia	2
CO - Colombia	2
IE - Irlanda	2
IQ - Iraq	2
JM - Giamaica	2
JP - Giappone	2
KE - Kenya	2
MA - Marocco	2
MT - Malta	2
PK - Pakistan	2
PT - Portogallo	2
TN - Tunisia	2
AL - Albania	1
AT - Austria	1
AZ - Azerbaigian	1
BH - Bahrain	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
ET - Etiopia	1
HU - Ungheria	1
IL - Israele	1
JO - Giordania	1
KZ - Kazakistan	1
MD - Moldavia	1
MK - Macedonia	1
ML - Mali	1
NO - Norvegia	1
PY - Paraguay	1
TH - Thailandia	1
VE - Venezuela	1
Totale	1.583

Nome	#
Clinical and serological profile of primary biliary cirrhosis in men	195
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants	174
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation	167
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis	166
De novo autoimmune hepatitis in liver transplant: State-of-the-art review	159
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis	159
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score	157
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways	149
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies	142
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program	131
Totale	1.599

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	39	0	0	0	0	0	0	0	0	0	0	38	1
2021/2022	169	29	8	10	8	0	4	4	14	23	22	24	23
2022/2023	215	32	24	19	23	22	40	1	20	20	1	8	5
2023/2024	109	1	10	5	22	27	1	20	7	2	2	0	12
2024/2025	369	7	2	4	27	81	60	13	26	61	9	21	58
2025/2026	647	51	17	36	64	128	66	97	34	68	86	0	0
Totale													1.599